Category Archives: AZBio News
Life Sciences Workforce Collaborative Releases 2025 National Workforce Trends Report Amid Industry Crossroads
Boston, MA, June 24, 2025 – The Life Sciences Workforce Collaborative (LSWC), formerly the Coalition of State Bioscience Institutes (CSBI), today released its 2025 National Life Sciences Workforce Trends Report, the seventh edition of this landmark study, at the 2025 BIO International Convention in Boston.
Developed in partnership with TEConomy Partners, LLC, with support from InnovATEBIO, the National Biotechnology Education Center, the biennial report captures an evolving talent landscape across the U.S. life sciences sector. Drawing on survey responses from over 500 companies, 200 executive interviews, and 2.9 million job postings, the 2025 edition reflects a more complex, cautious industry posture as companies respond to macroeconomic pressures, talent availability, and rapid digital transformation.¹Continue reading
Working to diagnose valley fever more quickly
A rapid test, developed by an ASU professor working with Mayo Clinic, could be available for use by the end of the year.Continue reading
As Congress Focuses on the Budget – Life Science Leaders Focus on an EPIC solution.
From full page ads in the Boston Globe to panels of thought leaders at BIO 2025,and podcasts, leaders are highlighting the problems being created by the Pill Penalty that is part of the Inflation Reduction Act. As Congress works through the Budget Reconciliation Process, the EPIC Act could be a solution.Continue reading
Peter Pellerito, Senior Policy Advisor with Biotechnology Innovation Organization, Honored with AURP Vision Award
Tucson, AZ, and College Park, MD, June 20, 2025 – The Association of University Research Parks (AURP) this week presented the AURP Vision Award to Peter Pellerito, Senior Policy Advisor at the Biotechnology Innovation Organization (BIO), during the AURP BIO Health Caucus (held in advance of the BIO 2025 International Convention in Boston).Continue reading
Caris Life Sciences Completes Initial Public Offering (IPO)
Reuters reports that Caris Life Sciences raised $494.1 million in its Nasdaq initial public offering
C-Path’s Translational Therapeutics Accelerator Announces New Grant Award for Drug Development Project in Type 1 Diabetes
TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment for type 1 diabetes (T1D). Continue reading
Life Sciences Workforce Collaborative (LSWC) Officially Launches to Strengthen Talent Pipelines Across the U.S.
Wexford Science & Technology Launches Pre-Leasing for 800 PBC
Builds on Momentum of PBC, ASU Health With 850 PBC Nearing Full CapacityContinue reading